Anna M. Koppin, BS (she/her/hers)

UNIVERSITY OF MINNESOTA
Minneapolis, MN, United States

Anna Koppin is a third-year PhD candidate in the Biochemistry, Molecular Biology, and Biophysics Program at University of Minnesota. Her research in Dr. Thu H. Truong’s laboratory focuses on estrogen receptor positive (ER+) breast cancer, with an emphasis on the molecular mechanisms driving therapy resistance and disease recurrence. Her current work investigates how metabolic reprogramming promotes ER+ breast cancer therapy resistance, recurrence, and metastasis.

Disclosure information not submitted.

Presentation(s):

• MON-267 - Progesterone Receptor Binding Interactions in Therapy-Resistant ER+ Breast Cancer

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• ORF48-08 - Investigating Progesterone Receptor-Driven Actions in Therapy-Resistant ER+ Breast Cancer

  Monday, June 15, 2026
  3:00 PM - 3:15 PM CT